newsfilter
← Latest News
ACCESS Newswire·

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Contracts signed for Animal Study GLP-1-A26-1KELOWNA, BC / ACCESS Newswire / April 15, 2026 / Lexaria Bioscience Corp. , , a global innovator in drug delivery platforms, is